These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 1472691)

  • 1. N-methyl-D-aspartic acid injected peripherally stimulates oxytocin and vasopressin release.
    Jezová D; Michajlovskij N
    Endocr Regul; 1992 Jun; 26(2):73-5. PubMed ID: 1472691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centrally administered galanin modifies vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of euhydrated and dehydrated rats.
    Ciosek J; Cisowska A
    J Physiol Pharmacol; 2003 Dec; 54(4):625-41. PubMed ID: 14726616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective activation of glutamate receptor NMDA subtype induces plasma vasopressin increase in rats.
    Steardo L; Steardo MD; Mazzoccoli M; Testa N; Cuomo V
    Acta Neurol (Napoli); 1994 Dec; 16(5-6):235-9. PubMed ID: 7709793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potentiation of metaphit-induced audiogenic epilepsy with N-methyl-D-aspartate in rats].
    Stanojlović O; Zivanović D; Susić V
    Srp Arh Celok Lek; 2000; 128(9-10):316-21. PubMed ID: 11255685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anteroventral third ventricular N-methyl-D-aspartate receptors, but not metabotropic glutamate receptors are involved in hemorrhagic AVP secretion.
    Yamaguchi K; Watanabe K
    Brain Res Bull; 2005 Jul; 66(1):59-69. PubMed ID: 15925145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid modulation of atrial natriuretic peptide, oxytocin, vasopressin and Fos expression in response to osmotic, angiotensinergic and cholinergic stimulation.
    Lauand F; Ruginsk SG; Rodrigues HL; Reis WL; de Castro M; Elias LL; Antunes-Rodrigues J
    Neuroscience; 2007 Jun; 147(1):247-57. PubMed ID: 17524563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin-releasing hormone (TRH) modulates vasopressin and oxytocin release from the hypothalamo-neurohypophysial system in dehydrated rats.
    Ciosek J; Guzek JW; Orłowska-Majdak M
    J Physiol Pharmacol; 1993 Sep; 44(3):293-302. PubMed ID: 8241530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
    Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
    Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus.
    Forsling ML; Fallon JK; Shah D; Tilbrook GS; Cowan DA; Kicman AT; Hutt AJ
    Br J Pharmacol; 2002 Feb; 135(3):649-56. PubMed ID: 11834612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin and oxytocin release and the thyroid function.
    Ciosek J; Drobnik J
    J Physiol Pharmacol; 2004 Jun; 55(2):423-41. PubMed ID: 15213363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Morris water maze testing on the neuroendocrine stress response and intrahypothalamic release of vasopressin and oxytocin in the rat.
    Engelmann M; Ebner K; Landgraf R; Wotjak CT
    Horm Behav; 2006 Sep; 50(3):496-501. PubMed ID: 16875693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurokinin A and the neurohypophysial response to melatonin: in vitro studies.
    Juszczak M
    J Physiol Pharmacol; 2002 Dec; 53(4 Pt 2):823-34. PubMed ID: 12510866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of gaseous neuromodulators in vasopressin and oxytocin release induced by endotoxin in rats.
    Giusti-Paiva A; Elias LL; Antunes-Rodrigues J
    Neurosci Lett; 2005 Jun; 381(3):320-4. PubMed ID: 15896492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of estrogen receptor-beta in regulation of vasopressin and oxytocin release in vitro.
    Somponpun S; Sladek CD
    Endocrinology; 2002 Aug; 143(8):2899-904. PubMed ID: 12130554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain angiotensin-II partially mediates the effects of relaxin on vasopressin and oxytocin release in anesthetized rats.
    Geddes BJ; Parry LJ; Summerlee AJ
    Endocrinology; 1994 Mar; 134(3):1188-92. PubMed ID: 8119158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin content in the venous blood outflowing from the vicinity of the cavernous sinus and from the femoral vein.
    Goraca A
    Endocr Regul; 2004 Sep; 38(3):119-25. PubMed ID: 15693290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of adrenocorticotropin but not prolactin and catecholamine release by N-methyl-aspartic acid.
    Jezová D; Oliver C; Jurcovicová J
    Neuroendocrinology; 1991 Nov; 54(5):488-92. PubMed ID: 1660964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a histamine H2-receptor antagonist, ranitidine on the vasopressin and oxytocin responses to novelty stress in the rat.
    Yagi K
    Neurosci Res; 1994 Jun; 19(4):357-64. PubMed ID: 7916447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of neurophysin, oxytocin and arginine vasopressin in the rat.
    Burton AM; Forsling ML; Martin MJ
    J Physiol; 1971; 217 Suppl(Suppl):23P-24P. PubMed ID: 5571927
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physiological mechanisms controlling the release of oxytocin and vasopressin].
    Traczyk WZ
    Ginekol Pol; 1974 Aug; 45(8):923-6. PubMed ID: 4410400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.